Clearmind Medicine Inc. Comprehensive Income
Clearmind Medicine Inc. (CMND) reported Comprehensive Income of -$3.85 million for the 3-month period ending 2026-01-31, per its 6-K filed 2026-03-12.
Financial Statements › Income Statement
ifrs-full:ComprehensiveIncome · last filed 2026-03-12
CAD
| Period end | Comprehensive Income 12 month |
|---|---|
| 2022-10-31 | -9.44M CAD 20-F · filed 2023-02-06 |
USD
| Period end | Comprehensive Income 3 month | Comprehensive Income 6 month | Comprehensive Income 9 month | Comprehensive Income 12 month |
|---|---|---|---|---|
| 2026-01-31 | -$3.85M 6-K · filed 2026-03-12 | -$4.54M derived: sum of 2 quarters · filed 2026-03-12 | -$5.86M derived: sum of 3 quarters · filed 2026-03-12 | -$6.64M derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-10-31 | -$687.84K derived: 20-F 12 month − 6-K 9 month · filed 2026-01-20 | -$2.00M derived: sum of 2 quarters · filed 2026-01-20 | -$2.79M derived: sum of 3 quarters · filed 2026-01-20 | -$3.86M 20-F · filed 2026-01-20 |
| 2025-07-31 | -$1.31M 6-K · filed 2025-09-11 | -$2.10M derived: sum of 2 quarters · filed 2025-09-11 | -$3.17M 6-K · filed 2025-09-11 | -$4.05M derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-04-30 | -$783.93K 6-K · filed 2025-06-12 | -$1.86M 6-K · filed 2025-06-12 | -$2.74M derived: sum of 3 quarters · filed 2026-03-12 | -$4.83M derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-01-31 | -$1.07M 6-K · filed 2026-03-12 | -$1.96M derived: sum of 2 quarters · filed 2026-03-12 | -$4.05M derived: sum of 3 quarters · filed 2026-03-12 | -$4.96M derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-10-31 | -$884.74K derived: 20-F 12 month − 6-K 9 month · filed 2026-01-20 | -$2.98M derived: sum of 2 quarters · filed 2026-01-20 | -$3.89M derived: sum of 3 quarters · filed 2026-01-20 | -$5.25M 20-F · filed 2026-01-20 |
| 2024-07-31 | -$2.09M 6-K · filed 2025-09-11 | -$3.00M derived: sum of 2 quarters · filed 2025-09-11 | -$4.37M 6-K · filed 2025-09-11 | |
| 2024-04-30 | -$908.22K 6-K · filed 2025-06-12 | -$2.28M 6-K · filed 2025-06-12 | ||
| 2024-01-31 | -$1.37M 6-K · filed 2025-03-13 | |||
| 2023-10-31 | -$8.62M 20-F · filed 2026-01-20 | |||
| 2022-10-31 | -$6.92M 20-F · filed 2025-01-22 | |||
| 2021-10-31 | -$2.73M 20-F/A · filed 2024-03-18 |